Roadmaps to the Intertwined IP and Regulatory Regimes in China
May 13, 2020 9:00 AM to 10:00 AM
60 Minutes of MCLE
Moderator: Jeremy K. McKown, Janssen R&D, New Brunswick, NJ
TopicsDevelopments in pharmaceutical IP and regulatory coordination efforts to stimulate faster and better pharmaceutical development in China
Juhua Luo, CCPIT Patent and Trademark Law Office, Beijing, China
Using Patent Law and Policy for Incentivizing Green Technology Innovation in China
Wen Cao, Principal of Shanghai Office of NTD, Shanghai, China
Presented by the IP Practice in China Committee and the US Group of AIPPI
CCPIT Patent and Trademark Law OfficeMr. Luo's practice focuses mainly on prosecution of patent.
McKown, Jeremy K.
Johnson & Johnson | Global Patent HeadJeremy is the Global Patent Head of Johnson & Johnson’s pharmaceutical business, where he manages a global team of attorneys and professionals focused on creating robust patent portfolios and providing strategic counsel to its’ Innovative Medicine companies. In addition, he advises on material R&D transactions and IP litigations, and actively works with external trade associations to ensure we have meaningful IP policies. Previously, he led the R&D Legal team responsible for drafting and negotiating complex agreements for J&J’s Innovative Medicine companies.
Shanghai Office of NTD | Senior PartnerMs. Cao serves as the principal of NTD Shanghai Office.